CRBN modulates synuclein fibrillation via degradation of DNAJB1 in mouse model of Parkinson disease

Abstract Cereblon (CRBN) is a substrate recruiter for CRL4CRBN E3 ubiquitin ligase system playing a plethora of pivotal roles for biological systems. Here, we identified DNAJB1 (DJ1) as endogenous substrate of CRBN and report how CRBN influences the aggregation and toxicity of alpha-synuclein (α-SYN...

Full description

Saved in:
Bibliographic Details
Main Authors: Uroos Akber, Jun-Hyung Jung, Heewoong Yoon, Jiwon Seo, Chul-Seung Park
Format: Article
Language:English
Published: Nature Portfolio 2024-10-01
Series:npj Parkinson's Disease
Online Access:https://doi.org/10.1038/s41531-024-00801-3
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850203782075383808
author Uroos Akber
Jun-Hyung Jung
Heewoong Yoon
Jiwon Seo
Chul-Seung Park
author_facet Uroos Akber
Jun-Hyung Jung
Heewoong Yoon
Jiwon Seo
Chul-Seung Park
author_sort Uroos Akber
collection DOAJ
description Abstract Cereblon (CRBN) is a substrate recruiter for CRL4CRBN E3 ubiquitin ligase system playing a plethora of pivotal roles for biological systems. Here, we identified DNAJB1 (DJ1) as endogenous substrate of CRBN and report how CRBN influences the aggregation and toxicity of alpha-synuclein (α-SYN) via modulation of DJ1. CRBN interferes with molecular activities of DJ1 in vitro, in cells, and in vivo resulting in a reduced disaggregation of α-SYN fibrils, increased formation of preformed fibrils (PFFs) of α-SYN, and high susceptibility of mice to MPTP and PFF-induced neurotoxicity. Depletion of Crbn improves the behavioral and biochemical responses of mice towards neurotoxic insult. Finally, we designed a peptide inhibitor to inhibit the recruitment of DJ1 to CRBN for ubiquitination, resulting in an enhanced supply of DJ1 to counteract the toxicity of aggregated α-SYN. Our data has important implications for development of CRBN-targeting therapies that could prevent or delay progression of neurodegenerative synucleinopathy.
format Article
id doaj-art-1ebdf84152bd4e569c2184a300d583a1
institution OA Journals
issn 2373-8057
language English
publishDate 2024-10-01
publisher Nature Portfolio
record_format Article
series npj Parkinson's Disease
spelling doaj-art-1ebdf84152bd4e569c2184a300d583a12025-08-20T02:11:25ZengNature Portfolionpj Parkinson's Disease2373-80572024-10-0110111410.1038/s41531-024-00801-3CRBN modulates synuclein fibrillation via degradation of DNAJB1 in mouse model of Parkinson diseaseUroos Akber0Jun-Hyung Jung1Heewoong Yoon2Jiwon Seo3Chul-Seung Park4Laboratory of Molecular Neurobiology, School of Life Sciences, Gwangju Institute of Science and Technology (GIST)Laboratory of Molecular Neurobiology, School of Life Sciences, Gwangju Institute of Science and Technology (GIST)Department of Chemistry, Peptide Drug Discovery Laboratory, Gwangju Institute of Science and Technology (GIST)Department of Chemistry, Peptide Drug Discovery Laboratory, Gwangju Institute of Science and Technology (GIST)Laboratory of Molecular Neurobiology, School of Life Sciences, Gwangju Institute of Science and Technology (GIST)Abstract Cereblon (CRBN) is a substrate recruiter for CRL4CRBN E3 ubiquitin ligase system playing a plethora of pivotal roles for biological systems. Here, we identified DNAJB1 (DJ1) as endogenous substrate of CRBN and report how CRBN influences the aggregation and toxicity of alpha-synuclein (α-SYN) via modulation of DJ1. CRBN interferes with molecular activities of DJ1 in vitro, in cells, and in vivo resulting in a reduced disaggregation of α-SYN fibrils, increased formation of preformed fibrils (PFFs) of α-SYN, and high susceptibility of mice to MPTP and PFF-induced neurotoxicity. Depletion of Crbn improves the behavioral and biochemical responses of mice towards neurotoxic insult. Finally, we designed a peptide inhibitor to inhibit the recruitment of DJ1 to CRBN for ubiquitination, resulting in an enhanced supply of DJ1 to counteract the toxicity of aggregated α-SYN. Our data has important implications for development of CRBN-targeting therapies that could prevent or delay progression of neurodegenerative synucleinopathy.https://doi.org/10.1038/s41531-024-00801-3
spellingShingle Uroos Akber
Jun-Hyung Jung
Heewoong Yoon
Jiwon Seo
Chul-Seung Park
CRBN modulates synuclein fibrillation via degradation of DNAJB1 in mouse model of Parkinson disease
npj Parkinson's Disease
title CRBN modulates synuclein fibrillation via degradation of DNAJB1 in mouse model of Parkinson disease
title_full CRBN modulates synuclein fibrillation via degradation of DNAJB1 in mouse model of Parkinson disease
title_fullStr CRBN modulates synuclein fibrillation via degradation of DNAJB1 in mouse model of Parkinson disease
title_full_unstemmed CRBN modulates synuclein fibrillation via degradation of DNAJB1 in mouse model of Parkinson disease
title_short CRBN modulates synuclein fibrillation via degradation of DNAJB1 in mouse model of Parkinson disease
title_sort crbn modulates synuclein fibrillation via degradation of dnajb1 in mouse model of parkinson disease
url https://doi.org/10.1038/s41531-024-00801-3
work_keys_str_mv AT uroosakber crbnmodulatessynucleinfibrillationviadegradationofdnajb1inmousemodelofparkinsondisease
AT junhyungjung crbnmodulatessynucleinfibrillationviadegradationofdnajb1inmousemodelofparkinsondisease
AT heewoongyoon crbnmodulatessynucleinfibrillationviadegradationofdnajb1inmousemodelofparkinsondisease
AT jiwonseo crbnmodulatessynucleinfibrillationviadegradationofdnajb1inmousemodelofparkinsondisease
AT chulseungpark crbnmodulatessynucleinfibrillationviadegradationofdnajb1inmousemodelofparkinsondisease